Intercept Pharmaceuticals, Inc. (ICPT) financial statements (2021 and earlier)

Company profile

Business Address 10 HUDSON YARDS, 37TH FLOOR
NEW YORK, NY 10001
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments470653436415689628240
Cash and cash equivalents58704370443320
Short-term investments412583393345646595220
Restricted cash and investments85     
Receivables423826179  
Inventory, net of allowances, customer advances and progress billings98732  
Inventory98732  
Prepaid expense   156104
Other undisclosed current assets181713(1)143
Total current assets:546721482448708642246
Noncurrent Assets
Inventory, Noncurrent98     
Property, plant and equipment65101611106
Other noncurrent assets1213     
Other undisclosed noncurrent assets7716202042
Total noncurrent assets:3534273631148
TOTAL ASSETS:580755509484739656254
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10781404233463
Accounts payable2519127743
Accrued liabilities472877730 
Employee-related liabilities272620271911 
Interest and dividends payable88     
Debt 6     
Deferred revenue and credits22622
Other undisclosed current liabilities7274736140 10
Total current liabilities:179162114104794715
Noncurrent Liabilities
Long-term debt and lease obligation561532371356341  
Long-term debt, excluding current maturities561532371356341  
Liabilities, other than long-term debt8958468
Deferred revenue and credits13468
Other liabilities8946   
Total noncurrent liabilities:56854137636434668
Total liabilities:7477034904684245423
Stockholders' equity
Stockholders' equity attributable to parent(167)521916315602231
Common stock0000000
Additional paid in capital2,2342,1761,8001,4871,4261,300700
Accumulated other comprehensive loss(2)(1)(2)(1)(3)(2)(0)
Accumulated deficit(2,398)(2,123)(1,779)(1,470)(1,108)(696)(469)
Total stockholders' equity:(167)521916315602231
TOTAL LIABILITIES AND EQUITY:580755509484739656254

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues3132521801312532
Revenue, net1312532
Cost of revenue(5)(4)(3)(1)   
Cost of goods and services sold  (3)(1)   
Gross profit:3072481771302532
Operating expenses(539)(560)(465)(467)(427)(232)(115)
Other operating income, net      1
Other undisclosed operating income  31   
Operating loss:(231)(312)(285)(336)(403)(229)(113)
Nonoperating income (expense)(44)(32)(24)(25)(10)3(170)
Investment income, nonoperating     (6)(3)
Other nonoperating income49754  
Interest and debt expense(48)(41)(31)(29)(14)  
Other undisclosed income from continuing operations before equity method investments, income taxes4841312914  
Net loss:(275)(345)(309)(360)(413)(226)(283)
Other undisclosed net loss attributable to parent      (0)
Net loss available to common stockholders, diluted:(275)(345)(309)(360)(413)(226)(283)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(275)(345)(309)(360)(413)(226)(283)
Other comprehensive income (loss)(1)1 (358)(413)(228)(284)
Comprehensive loss:(276)(344)(309)(719)(826)(455)(566)
Other undisclosed comprehensive loss, net of tax, attributable to parent  (1)    
Comprehensive loss, net of tax, attributable to parent:(276)(344)(311)(719)(826)(455)(566)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: